PK in patients with impaired renal function (Ep. 12)
Release Date:
In today’s episode I discuss the evaluation of pharmacokinetics in patients with impaired renal function. I include information from both the US FDA and EMA guidance documents linked below. I discuss the determination of when a dedicated renal impairment study is needed, characteristics of the study design and how to analyze and interpret the results.
Links discussed in the show:
• FDA guidance on PK in patients with impaired renal function
• EMA guidance on Evaluation of PK in patients with decreased renal function
• You can connect with me on LinkedIn and send me a message.
• Send me a message
• Sign up for my newsletter
Copyright Teuscher Solutions LLC
All Rights Reserved
PK in patients with impaired renal function (Ep. 12)